TAF
BIO icon

Tredje AP-fonden’s Bio-Rad Laboratories Class A BIO Stock Holding History

Tredje AP-fonden’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,684
Closed -$410K – 383
2025
Q1 		$410K Hold
1,684
– – ﹤0.01% 426
2024
Q4 		$553K Sell
1,684
-1,683
-50% -$571K 0.01% 460
2024
Q3 		$1.13M Hold
3,367
– – 0.01% 434
2024
Q2 		$920K Sell
3,367
-53
-2% -$15.4K 0.01% 449
2024
Q1 		$1.18M Hold
3,420
– – 0.01% 451
2023
Q4 		$1.1M Sell
3,420
-227
-6% -$71.1K 0.01% 482
2023
Q3 		$1.31M Sell
3,647
-336
-8% -$130K 0.02% 446
2023
Q2 		$1.51M Sell
3,983
-740
-16% -$301K 0.02% 437
2023
Q1 		$2.26M Buy
4,723
+242
+5% +$113K 0.04% 367
2022
Q4 		$1.88M Buy
4,481
+63
+1% +$25.4K 0.03% 385
2022
Q3 		$1.84M Buy
+4,418
New +$2.2M 0.04% 361

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Tredje AP-fonden's BIO Position: Q2 2025 in Review

Tredje AP-fonden sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 1,684 shares — an estimated $410K sold.

Tredje AP-fonden first reported a position in BIO in Q3 2022 and held it in 11 quarters. The position peaked at $2.26M in Q1 2023. 383 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Tredje AP-fonden reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Tredje AP-fonden sold 1,684 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $410K.
  • Tredje AP-fonden first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and held it in 11 quarters.
  • Tredje AP-fonden's Bio-Rad Laboratories Class A position peaked at $2.26M in Q1 2023.
  • 383 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Tredje AP-fonden's 13F filing for Q2 2025, filed 5 Aug 2025.